Sign In
Buy LLY
$1,083.23
+18.39 (+1.73%)
At Close: Jun 03, 2026
One Alzheimer's drug has failed, but investors are still betting on Biogen and Lilly treatments
02:34pm, Monday, 14'th Nov 2022
Biogen's BIIB, +4.96% stock is rising again as investors double down on the company's promising yet still experimental treatment for Alzheimer's disease.
Eli Lilly's Twitter Fiasco Continues As Drugmaker Reportedly Pulls 'Millions' In Twitter Ads
01:20pm, Monday, 14'th Nov 2022
Eli Lilly reportedly is pulling advertising from Twitter after a fake account promised free insulin in a fiasco that depressed LLY stock. The post Eli Lilly's Twitter Fiasco Continues As Drugmaker Rep
Eli Lilly stock plunged after fake blue check tweet
12:28pm, Monday, 14'th Nov 2022
Yahoo Finance Live anchors discuss the decline in stock for Eli Lilly after an unofficial verified account tweeted that insulin was now free.
Eli Lilly stock starts on front foot after rival Alzheimer trial fails
10:09am, Monday, 14'th Nov 2022
Eli Lilly and Co (NYSE:LLY) stock was moving higher as Roche revealed that an experimental rival treatment for Alzheimer's failed in a Phase III clinical trial. Roche earlier today announced that its
Eli Lilly stock starts fresh week on front foot after rival Alzheimer trial fails
10:03am, Monday, 14'th Nov 2022
Eli Lilly and Co (NYSE:LLY) stock was moving higher as Roche revealed that an experimental rival treatment for Alzheimer's failed in a Phase III clinical trial. Roche earlier today announced that its
Roche's Alzheimer's Drug Fails In Phase 3; Here's The Fallout For Biogen, Lilly, Prothena And Others
09:17am, Monday, 14'th Nov 2022
Roche said its experimental Alzheimer's treatment failed in two final-phase studies, leading Biogen stock to surge while others crumbled. The post Roche's Alzheimer's Drug Fails In Phase 3; Here's The
Twitter Shaves $15 Billon Off Eli Lilly's Market Cap
09:30am, Saturday, 12'th Nov 2022
Somehow, someone made it through Twitter's system to block accounts people use to impersonate other people and companies.
Eli Lilly stock dips after imposter account posts prank on Twitter
04:45pm, Friday, 11'th Nov 2022
Shares of Eli Lilly ticked downward after a fake account posed as the company on Twitter.
Why Are Healthcare Stocks Down Today?
04:31pm, Friday, 11'th Nov 2022
A scandal at Twitter is pushing healthcare stocks down today. Since Elon Musk took over the platform, much controversy has risen regarding its verification system.
Patience At The Right Time Made LLY Stock A Swing Trading Winner
04:30pm, Friday, 11'th Nov 2022
Patience is a virtue but knowing the right time to apply it helps make you money. The post Patience At The Right Time Made LLY Stock A Swing Trading Winner appeared first on Investor's Business Daily.
Eli Lilly shares fall after fake verified account tweets 'insulin is free now'
03:01pm, Friday, 11'th Nov 2022
Elon Musk's new pay-$8-for-Twitter-verification system has gone awry in a matter of days. Now, instead of just costing Twitter money, other companies are taking losses too.
Kari Lake, Lockheed Martin And Eli Lilly—Here Are The Companies, Celebrities And Politicians Impersonated In Twitter Blue Chaos
01:15pm, Friday, 11'th Nov 2022
Musk suspended his new verification program Twitter Blue on Friday and announced new rules for parody accounts.
Eli Lilly Clarifies It's Not Offering Free Insulin After Tweet From Fake Verified Account—As Chaos Unfolds On Twitter
05:34pm, Thursday, 10'th Nov 2022
New Twitter owner Elon Musk has come under fire for launching Twitter Blue, a program that allows any account to be verified for a monthly subscription, leading to widespread misinformation on the pla
CMI Stock Revisited: What Made It Work This Time?
05:06pm, Friday, 04'th Nov 2022
Two trades in the same stock just weeks apart. What was the secret of success the second time around?
Trading Ideas On The Upcoming CTAD 2022 Conference
03:27pm, Wednesday, 02'nd Nov 2022
The Clinical Trials on Alzheimer's Conference will take place from November 29, 2022 to December 2, 2022. Representatives of several listed companies will present data, including Eisai, Anavex, BioVie
